(PharmaNewsWire.Com, January 05, 2018 ) According to the report Global Companion Diagnostics Market published by Market Data Forecast, the global market is projected to reach USD 8.88 billion by 2021, at a CAGR of 21.6% from 2016 to 2021.
The Global Companion Diagnostics market is recognized to be as a growing need of tailored medications and modified cancer treatment, increasing adoption of companion diagnostic tests by end users such as biotechnology and pharmaceutical, firms and reference laboratories, and encouragement by regulatory bodies such as EMA and FDA to implement developments of companion diagnostic test at the initial phases of drug development techniques.
Companion diagnostics is a relatively new branch of diagnostics that is expected to grow at a fast pace in coming days as well as increased its market demand globally. The applications of Companion diagnostic are to regulate patient personal molecular profile in supporting to determine which therapy will work for the patient. This diagnostic procedure needs a biopsied matter or a tissue to contact the appearance of biomarker protein or mutant. Companion diagnostics are also used in defining Companion biomarker, which helps foresee response to toxicity.
The factors influencing the Global Market for Companion Diagnostics Market, either positively or negatively are presented in the DROC analysis. Some of the things discussed in the section are asking adoption of companion diagnostic tests, encouragement from regulatory bodies and emerging advanced technologies such as next-generation sequencing (NGS). To seizure this market, pharmaceutical companies are motivated to enter the global market through strategic achievements and alliances with NGS platform diagnostic firms
For granular level understanding, the Companion Diagnostics Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.
By Indications: Oncology • Colorectal Cancer • Breast Cancer • Lung Cancer • Gastric Cancer • Melanoma Inflammation and Autoimmune Diseases Cardiovascular Diseases Central Nervous System Disorders Virology Diseases
Based on geography the market is analyzed under various regions namely, North America, Latin America, Europe, Asia-Pacific and the Middle East. Due to technological advancement and huge investment in research & development, North America is leading the companion diagnostic market. While Europe and Asia-Pacific are expected to grow at significant growth rate.
North America Companion Diagnostics Market Europe Companion Diagnostics Market Asia-Pacific Companion Diagnostics Market Latin America Companion Diagnostics Market Middle-East and Africa Companion Diagnostics Market
Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.
The Companion Diagnostics Market study offers the following deliverables: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming • Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: